Hudson Executive Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KATE
Kate Spade & Company
KATE
|
+$13.6M |
| 2 |
AtriCure
ATRC
|
+$10.3M |
| 3 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$6.32M |
| 4 |
CBM
Cambrex Corporation
CBM
|
+$3.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$29.2M |
| 2 |
CMA
Comerica
CMA
|
+$23.9M |
| 3 |
Dillards
DDS
|
+$8.65M |
| 4 |
Tenet Healthcare
THC
|
+$4.33M |
| 5 |
CIT
CIT Group Inc.
CIT
|
+$433K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 44.75% |
| 2 | Financials | 20.73% |
| 3 | Technology | 13.15% |
| 4 | Consumer Discretionary | 5.5% |
| 5 | Consumer Staples | 0% |
Similar funds
Hudson Executive Capital's Q4 2016 Portfolio in Review
As of Q4 2016, Hudson Executive Capital held 14 positions worth $281M, down 50% from $564M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Hudson Executive Capital withdrew a net $314M in Q4 2016, closing 3 positions and reducing 3 holdings. Its most notable exit was The WhiteWave Foods Company, an estimated $29.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 45% of assets, up from 19% a quarter earlier, followed by Financials and Technology.
Against the trend, Hudson Executive Capital opened a new position in Kate Spade & Company worth $15.5M.
- Hudson Executive Capital's largest Q4 2016 buy was Kate Spade & Company: 829,000 shares worth $15.5M.
- Hudson Executive Capital added most to AtriCure in Q4 2016, an estimated $10.3M increase.
- Hudson Executive Capital's biggest Q4 2016 reduction was Comerica, cutting an estimated $23.9M.
- Hudson Executive Capital fully exited The WhiteWave Foods Company in Q4 2016, selling an estimated $29.2M.
- Hudson Executive Capital's ten largest holdings make up 99% of its $281M portfolio in Q4 2016.
- Hudson Executive Capital opened 3 new positions and closed 3 in Q4 2016.
- Hudson Executive Capital's portfolio value fell 50% quarter-over-quarter to $281M.
Based on Hudson Executive Capital's 13F filing for Q4 2016, filed 14 Feb 2017.